SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-12-10 13:23
Tx date 2025-12-10 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$18,445
+3,100 vol
$5.95 each 		987,972
Filed 2025-09-17 15:49
Tx date 2025-09-15 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$1,118
+253 vol
$4.42 each 		984,872
Filed 2025-09-17 15:48
Tx date 2025-09-15 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$5,565
+871 vol
$6.39 each 		984,619
Filed 2025-07-11 16:39
Tx date 2025-04-03 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options 		$-1,824,820
-182,482 vol
$10.00 each 		1,104,618
Filed 2025-06-18 16:28
Tx date 2025-06-15 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$1,274
+259 vol
$4.92 each 		983,748
Filed 2025-06-18 16:27
Tx date 2025-06-15 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$6,402
+1,060 vol
$6.04 each 		983,489
Filed 2025-04-04 19:30
Tx date 2025-04-01 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
57 - Exercise of rights 		$119,907
+19,434 vol
$6.17 each 		982,429
Filed 2025-04-04 19:29
Tx date 2025-04-01 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Performance stock Unit
57 - Exercise of rights 		$-135,001.52
-25,912 vol
$5.21 each 		119,284
Filed 2025-03-29 16:09
Tx date 2025-03-24 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Performance stock Unit
56 - Grant of rights 		$271,321
+43,691 vol
$6.21 each 		145,196
Filed 2025-03-29 16:06
Tx date 2025-03-24 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options 		$832,065
+133,988 vol
$6.21 each 		1,287,100
Filed 2025-03-20 15:39
Tx date 2025-03-15 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$1,038
+206 vol
$5.04 each 		962,995
Filed 2025-03-20 15:37
Tx date 2025-03-15 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$5,017
+839 vol
$5.98 each 		962,789
Filed 2024-12-18 11:23
Tx date 2024-12-15 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$7,063
+1,348 vol
$5.24 each 		961,950
Filed 2024-09-18 14:16
Tx date 2024-09-15 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$1,035
+184 vol
$5.63 each 		960,602
Filed 2024-09-18 14:16
Tx date 2024-09-15 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$5,020
+851 vol
$5.90 each 		960,418
Filed 2024-06-19 21:00
Tx date 2024-06-15 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$1,211
+232 vol
$5.22 each 		959,567
Filed 2024-06-19 21:00
Tx date 2024-06-15 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$5,581
+964 vol
$5.79 each 		959,335
Filed 2024-06-05 12:15
Tx date 2024-06-05 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$29,000
+5,000 vol
$5.80 each 		958,371
Filed 2024-05-29 12:34
Tx date 2024-05-28 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift 		$-5,443,740
-918,000 vol
$5.93 each 		20,760,733
Filed 2024-05-22 16:32
Tx date 2024-05-22 		$GUD
Knight Therapeutics Inc. 		Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
51 - Exercise of options 		$514,816
+91,118 vol
$5.65 each 		953,371